Breast cancer resistance protein substrate and inhibition evaluation: why, when, and how?

@article{Ware2014BreastCR,
  title={Breast cancer resistance protein substrate and inhibition evaluation: why, when, and how?},
  author={Joseph A. Ware and Bradley L Urquhart and Yuichi Sugiyama and Maciej J. Zamek-Gliszczynski},
  journal={Drug metabolism and disposition: the biological fate of chemicals},
  year={2014},
  volume={42 12},
  pages={
          1979-80
        }
}
We wish to thank [Poirier et al. (2014)][1] for their recently published manuscript, “The need for human breast cancer resistance protein substrate and inhibition evaluation in drug discovery and development: why, when, and how?” which attempted to contemporize many of the key concepts of breast 

Citations

Publications citing this paper.

Response to "Breast cancer resistance protein substrate and inhibition evaluation: why, when, and how?".

  • Drug metabolism and disposition: the biological fate of chemicals
  • 2014
VIEW 5 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

References

Publications referenced by this paper.
SHOWING 1-10 OF 12 REFERENCES